Zynex appoints Steven Dyson as CEO; founder Thomas Sandgaard moves to Chairman role to steer vision
1Zynex Inc. announced a significant leadership transition as Founder and longtime CEO Thomas Sandgaard steps into the role of Chairman of the Board and Chair of the Technology Committee, while Steven Dyson assumes the position of Chief Executive Officer.
In a joint conversation with Steve Darling from Proactive, Sandgaard explained that this move marks a strategic evolution for Zynex as it adapts to a dynamic healthcare environment. Sandgaard, who founded the company in 1996 and led it from inception to Nasdaq listing, emphasized that Dyson brings the leadership, experience, and global perspective necessary to take Zynex to the next level.
Steven Dyson joins Zynex with more than 25 years of international leadership experience in the medical technology and healthcare sectors. Most notably, Dyson served as a senior executive at Apax Partners, a leading private equity firm where he played key roles in scaling and exiting high-profile healthcare companies across Europe, North America, and Asia. His track record includes transformative roles at KCI, Rodenstock, Unilabs, Healthium Medtech, and Neuraxpharm, giving him a robust foundation in growth strategy, operational optimization, and global expansion.
At Zynex, Dyson will lead the company through a refined strategic focus, particularly targeting a more optimized payer mix, streamlined operations, and expanded market penetration in non-invasive pain management and medical diagnostic devices.
As Chairman, Sandgaard will continue to shape Zynex’s product and technology pipeline, ensuring its R&D efforts remain competitive and aligned with evolving healthcare trends, especially in pain relief solutions and wearable diagnostics.
This leadership evolution underscores Zynex’s commitment to growth, modernization, and value creation, with a steady hand at the helm and a fresh operational engine poised to accelerate the company’s trajectory in the medtech space.
#proactiveinvestors #zynexinc #nasdaq #zyxi #healthcare #ThomasSandgaard #CEOTransition #MedicalDevices #HealthcareLeadership #StevenDyson #ZynexInc #PainManagement #BusinessAnnouncement #MedicalDevices #LeadershipTransition #StevenDyson #ThomasSandgaard #NexWave #HealthcareInnovation #PainManagement #OpioidAlternative #ProactiveInvestors